Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Firebrick Pharma Limited ( (AU:FRE) ) has provided an update.
Firebrick Pharma has notified the market of the issue of 6,382,980 unquoted options, exercisable at $0.095 and expiring on 4 July 2028. The options, recorded under ASX code FREAF, were issued on 20 April 2026 as part of previously announced transactions, and are not intended to be quoted on the ASX, modestly altering the company’s unquoted capital base and potential future dilution profile for existing shareholders.
More about Firebrick Pharma Limited
Firebrick Pharma Limited, listed on the ASX under code FRE, operates in the pharmaceutical industry. The company focuses on developing and commercialising healthcare products, with its capital structure including various classes of quoted and unquoted equity securities used to support corporate and financing needs.
Average Trading Volume: 91,873
Technical Sentiment Signal: Buy
Current Market Cap: A$18.37M
For an in-depth examination of FRE stock, go to TipRanks’ Overview page.